LFB Biotechnologies S.A.S.U.

Insider

First SEC filing: Dec. 7, 2012 · Latest: Dec. 7, 2012

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

2 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 7, 2015	TGTX	X	2,500,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
May 7, 2015	TGTX	X	2,500,000	—	—	7,614,855 Direct	+48.88%	Acquired	(price as of 2026-08-21)
Feb. 17, 2015	TGTX	P	114,855	$6.53	$750,003	5,114,855 Direct	+2.30%	Acquired	745.0% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 7, 2015	TGTX	Warrants to Purchase Common Stock	Common Stock (2,500,000)	$0.00	Nov. 9, 2022	2,500,000	Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Dec. 7, 2012	TGTX	Common Stock	5,000,000	Direct
Dec. 7, 2012	TGTX	Warrants to purchase Common Stock→ Common Stock (2,500,000)	2,500,000	Direct